DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Thursday, May 2nd. Analysts expect DENTSPLY SIRONA to post earnings of $0.42 per share for the quarter. DENTSPLY SIRONA has set its FY 2024 guidance at 2.000-2.100 EPS and its FY24 guidance at $2.00-$2.10 EPS.Persons that are interested in participating in the company’s earnings conference call can do so using this link.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last released its quarterly earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $972.61 million. During the same period in the previous year, the company posted $0.46 earnings per share. The firm’s revenue was up 3.0% on a year-over-year basis. On average, analysts expect DENTSPLY SIRONA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
DENTSPLY SIRONA Trading Down 2.2 %
NASDAQ XRAY opened at $30.01 on Wednesday. The company has a quick ratio of 0.95, a current ratio of 1.38 and a debt-to-equity ratio of 0.55. DENTSPLY SIRONA has a twelve month low of $26.27 and a twelve month high of $43.24. The firm has a market capitalization of $6.22 billion, a PE ratio of -48.40, a P/E/G ratio of 1.24 and a beta of 0.98. The stock’s 50 day moving average is $32.40 and its 200 day moving average is $32.78.
DENTSPLY SIRONA Increases Dividend
Analyst Ratings Changes
Several research firms recently weighed in on XRAY. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Piper Sandler lifted their price target on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a research report on Friday, January 12th. Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, January 19th. Finally, SVB Leerink assumed coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They issued an “outperform” rating and a $42.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $39.50.
View Our Latest Stock Analysis on DENTSPLY SIRONA
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
- Five stocks we like better than DENTSPLY SIRONA
- Dividend Payout Ratio Calculator
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What are earnings reports?
- Hilton Demonstrates Asset Light is Right for Investors
- How to Invest in the Best Canadian StocksĀ
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.